Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

Conditions: Overactive Bladder; Benign Prostatic HyperplasiaIntervention: Drug: doxazosin plus tolterodine SRSponsors: Samsung Medical Center; Samsung Medical CenterRecruiting - verified June 2013

http://clinicaltrials.gov/ct2/show/NCT00922506?lup_s=05%2F13%2F2013&lup_d=30

Source: ClinicalTrials.gov - June 16, 2009 Category: Research Source Type: clinical trials

More News: Benign Prostatic Hyperplasia | Doxazosin | Overactive Bladder | Overactive Bladder Syndrome | Research